Mok Oh
Impact in
- Neurology top 10%
- Barrier Structure and Function Studies
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 5
- Oncology 6
- Pancreatic and Hepatic Oncology Research 2
- Neutropenia and Cancer Infections 2
- Co-authors
- Ivo Abraham (15 shared papers)Ali McBride (12 shared papers)Jung Wook Park (2 shared papers)Kohei Shitara (3 shared papers)Jennifer Martin (4 shared papers)Joanne Jeter (5 shared papers)Joseph Chao (1 shared paper)Yoon‐Koo Kang (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)ESMO Open (2 papers)Patient (1 paper)JAMA Dermatology (1 paper)Expert Opinion on Drug Safety (1 paper)
- Partner nations
- United StatesBelgiumJapan
In The Last Decade
Mok Oh
24 papers receiving 697 citations
Mok Oh's Hit Papers
Peers
Comparison fields: 5 of 60
- Neurology 105
- Gastroenterology 57
- Oncology 211
- Pulmonary and Respiratory Medicine 242
- Cancer Research 79
Countries citing papers authored by Mok Oh
This map shows the geographic impact of Mok Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mok Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mok Oh more than expected).
Fields of papers citing papers by Mok Oh
This network shows the impact of papers produced by Mok Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mok Oh. The network helps show where Mok Oh may publish in the future.
Co-authors
The 25 scholars most cited alongside Mok Oh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial Hit paper breakdown → | 2023 | 407 |
| 2 | 2019 | 95 | |
| 3 | 2018 | 90 | |
| 4 | 2018 | 26 | |
| 5 | 2020 | 15 | |
| 6 | 2024 | 13 | |
| 7 | 2020 | 13 | |
| 8 | 2022 | 7 | |
| 9 | 2023 | 6 | |
| 10 | 2020 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2021 | 4 | |
| 13 | 2022 | 4 | |
| 14 | 2022 | 3 | |
| 15 | 2022 | 2 | |
| 16 | 2020 | 2 | |
| 17 | 2019 | 1 | |
| 18 | 2019 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 2019 | 1 |
About Mok Oh
Mok Oh is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 706 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), BRCA gene mutations in cancer (4 papers), Barrier Structure and Function Studies (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Neutropenia and Cancer Infections (2 papers) and MRI in cancer diagnosis (1 paper). The work is most often cited by research in Neurology (105 citations), Gastroenterology (57 citations), Oncology (211 citations), Pulmonary and Respiratory Medicine (242 citations) and Cancer Research (79 citations). Mok Oh has collaborated with scholars based in United States, Belgium and Japan. Frequent co-authors include Ivo Abraham, Ali McBride, Jung Wook Park, Kohei Shitara, Jennifer Martin, Joanne Jeter, Joseph Chao, Yoon‐Koo Kang, Ahsan M. Arozullah and Florian Lordick. Their work appears in journals such as Journal of Clinical Oncology, ESMO Open, Patient, JAMA Dermatology and Expert Opinion on Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.